01-05-2024
|
|
|
Biocon Limited has informed the Exchange regarding 'Intimation of receipt of Demand Orders.'. |
|
|
|
30-04-2024
|
|
|
Biocon Limited has informed the Exchange regarding 'Receipt of Demand Orders'. |
|
|
|
25-04-2024
|
|
|
BIOCON LIMITED has informed the Exchange regarding Amalgamation/ Merger |
|
|
|
25-04-2024
|
|
|
Biocon Limited has informed the Exchange regarding 'Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015'. |
|
|
|
23-04-2024
|
|
|
Biocon Limited has informed the Exchange about Investor Meeting |
|
|
|
23-04-2024
|
|
|
Biocon Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results. |
|
|
|
20-04-2024
|
|
|
Biocon Limited has informed the Exchange regarding 'Notification'. |
|
|
|
17-04-2024
|
|
|
Biocon Limited has informed the Exchange about Investor Meeting |
|
|
|
17-04-2024
|
|
|
Biocon Limited has informed the Exchange regarding a press release dated April 17, 2024, titled "Biocon Limited signs an exclusive licensing and supply agreement for generic Ozempic (Semaglutide) commercialization in Brazil with Biomm S.A.". |
|
|
|
15-04-2024
|
|
|
Biocon Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 |
|
|
|
|
|